Nevro (NVRO) Announces Roderick MacLeod as CFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/13/2026
- Wall Street set for lower open as Iran tensions jolt sentiment; chip stocks fall
- SK Hynix’s record plunge drags down global chip stocks
- Oil gains over 3% as fresh military strikes threaten Hormuz shipments
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer
June 4, 2020 7:00 AM EDTREDWOOD CITY, Calif., June 4, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Roderick ("Rod") MacLeod as Chief Financial Officer, effective June 15, 2020, with global responsibility for Finance, IT and Customer Service. Mr. MacLeod succeeds Andrew Galligan, who is retiring but will remain with the Company during a transition period.
"Rod is a proven leader with a track record of success in finance and operations leadership. We are... More
